Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Telomerase-based therapies emerging slowly.

× No keyword cloud information.

6 in total

Review 1. Telomerase and the endocrine system.

Authors: Furio Pacini; Silvia Cantara; Marco Capezzone; Stefania Marchisotta
Journal: Nat Rev Endocrinol Date: 2011-03-29 Impact factor: 43.330

2. The combined use of known antiviral reverse transcriptase inhibitors AZT and DDI induce anticancer effects at low concentrations.

Authors: Thomas Aschacher; Sandra Sampl; Lisa Käser; David Bernhard; Andreas Spittler; Klaus Holzmann; Michael Bergmann
Journal: Neoplasia Date: 2012-01 Impact factor: 5.715

3. Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

Authors: Neelu Puri; Ryan T Pitman; Richard E Mulnix; Terrianne Erickson; Audra N Iness; Connie Vitali; Yutong Zhao; Ravi Salgia
Journal: Cancer Lett Date: 2013-09-14 Impact factor: 8.679

4. Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms.

Authors: Sarah K Brennan; Qiuju Wang; Robert Tressler; Calvin Harley; Ning Go; Ekaterina Bassett; Carol Ann Huff; Richard J Jones; William Matsui
Journal: PLoS One Date: 2010-09-01 Impact factor: 3.240

5. Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design.

Authors: Bently P Doonan; Azizul Haque
Journal: J Clin Cell Immunol Date: 2015-08-26

Review 6. Telomeres and Cancer.

Authors: Hueng-Chuen Fan; Fung-Wei Chang; Jeng-Dau Tsai; Kao-Min Lin; Chuan-Mu Chen; Shinn-Zong Lin; Ching-Ann Liu; Horng-Jyh Harn
Journal: Life (Basel) Date: 2021-12-16

6 in total